16 – 25 of 25
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2012
-
Mark
A Novel C3 Mutation Causing Increased Formation of the C3 Convertase in Familial Atypical Hemolytic Uremic Syndrome.
(
- Contribution to journal › Article
- 2011
-
Mark
Phenotypic Expression of ADAMTS13 in Glomerular Endothelial Cells
(
- Contribution to journal › Article
-
Mark
Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome.
(
- Contribution to journal › Article
- 2009
-
Mark
A novel mutation in the complement regulator clusterin in recurrent hemolytic uremic syndrome.
(
- Contribution to journal › Article
-
Mark
Shiga toxin and lipopolysaccharide induce platelet-leukocyte aggregates and tissue factor release, a thrombotic mechanism in hemolytic uremic syndrome.
(
- Contribution to journal › Article
- 2008
-
Mark
Platelet activation and tissue factor release in hemolytic uremic syndrome
(
- Thesis › Doctoral thesis (compilation)
-
Mark
A novel mutation in the complement regulator clusterin in recurrent haemolytic uraemic syndrome
(
- Contribution to journal › Published meeting abstract
-
Mark
Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation.
(
- Contribution to journal › Article
- 2006
-
Mark
Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets via TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome.
(
- Contribution to journal › Article
-
Mark
Platelet activation in hemolytic uremic syndrome.
(
- Contribution to journal › Scientific review
- « previous
- 1
- 2
- next »